Dr. Rashkovan completed her PhD in Experimental Medicine at McGill University, studying T-cell development in the lab of Dr. Tarik Möröy at the IRCM in Montreal. She then joined the lab of Dr. Adolfo Ferrando at the Columbia University Irving Medical Center in New York. During her postdoctoral fellowship, Dr. Rashkovan focused on Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) and the role of cholesterol biosynthesis in this high-risk leukemia.